Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus

Clinical Rheumatology

Volumn 27, Issue 11, 2008, Pages 1377-1385

  Abdel Nasser, Ahmed M ^a   Ghaleb, Rasha M ^a   Mahmoud, Jehan A ^a   Khairy, Wafaa ^a   Mahmoud, Refaat M ^a  

^a MINIA UNIVERSITY   (Egypt)

Author keywords

Anti ribosomal P antibody; Depression; NPSLE; Psychosis; SLE

Indexed keywords

ANTIMALARIAL AGENT; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; RIBOSOME PROTEIN P ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANAMNESIS; ANXIETY; ARTICLE; BLOOD ANALYSIS; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONFUSION; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEADACHE; HUMAN; LABORATORY TEST; MALE; MENTAL DISEASE; MOOD DISORDER; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; PSYCHOMETRY; PSYCHOSIS; RHEUMATOLOGY; SCHOOL CHILD; SEIZURE; SENSITIVITY AND SPECIFICITY; STROKE; SYMPTOM CHECKLIST 90; SYSTEMIC LUPUS ERYTHEMATOSUS; WECHSLER INTELLIGENCE SCALE;

ADOLESCENT; ADULT; ANTIBODIES, ANTINUCLEAR; CHILD; COHORT STUDIES; FEMALE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; MOOD DISORDERS; RIBOSOMAL PROTEINS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 53849097317     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-008-0921-1     Document Type: Article

References (39)

1. Cervera R, Khamashta MA, Font J et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82:299-308
2. Nadeau SE (2002) Neurologic manifestations of connective tissue disease. Neurol Clin 20:151-178
3. Danchenko N, Satia JA, Anthony MS (2006) Epidemiology of systemic lupus erythematosus: A comparison of worldwide disease burden. Lupus 15:308-318
4. Jacobsen S, Petersen J, Ullman S et al (1998) A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol 17:478-484
5. Hanly JG, McCurdy G, Fougere L et al (2004) Neuropsychiatric events in systemic lupus erythematosus: Attribution and clinical significance. J Rheumatol 31:2156-2162
6. Ainiala H, Loukkola J, Peltola J et al (2001) The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57:496-500
7. Brey RL, Holliday SL, Saklad AR et al (2002) Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions. Neurology 58:1214-1220
8. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 42:599-608
9. Hanly JG, Hong C, Smith S et al (1999) A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 42:728-734
10. Hochberg MC (1997) Updating the American College of Rheumatology Revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
11. Elkon KB, Parnassa AP, Foster CL (1985) Lupus autoantibodies target ribosomal P proteins. J Exp Med 162:459-471
12. Schneebaum AB, Singleton JD, West SG et al (1991) Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythamatosus. Am J Med 90:54-62
13. Nojima Y, Minota S, Yamada A et al (1992) Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus. Ann Rheum Dis 51:1053-1055
14. Press J, Palayew K, Laxer RM et al (1996) Anti-ribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis. Arthritis Rheum 99:671-676
15. Sato T, Uchiumi T, Ozawa T et al (1991) Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease. J Rheumatol 18:1681-1684
16. van Dam A, Nossent H, de Jong J et al (1991) Diagnostic value of antibodies against ribosomal phosphoproteins: A cross sectional and longitudinal study. J Rheumatol 18:1026-1034
17. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington (DC)
18. El-Behairy AA (1984) The Symptom Checklist-90-R. Cairo, El-Nahda El-Misrya
19. Wechsler D (1981) Wechsler adult intelligence scale-revised manual. Psychological, New York
20. Wechsler D (1971) Wechsler memory scale. Psychological, New York
21. Bombardier C, Gladman DD, Urowitz MB et al (1992) Derivation of the SLEDAI.A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630-640
22. Uribe AG, Vilá LM, McGwin G Jr, Sanchez ML, Reveille JD, Alarcón GS (2004) The systemic Lupus activity measure-revised, the Mexican systemic Lupus erythematosus disease activity index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol 31:1934-1940
23. Tzioufas AG, Tzortzakis NG, Panou-Pomonis E et al (2000) The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: A large cohort of consecutive patients and patients with active central nervous system disease. Ann Rheum Dis 59:99-104
24. Karassa FB, Loannidis JP, Toulomi G et al (2000) Risk factor for CNS involvement in systemic lupus erythematosus. QJM 93:169-174
25. Mok CC, Lau CS, Wong RWS et al (2001) Neuropsychatric manifestations and their clinical association in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 28:766-771
26. Isshi K, Hirohata S (1996) Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 39:1483-1490
27. Teh L-S, Lee MK, Wang F et al (1993) Anti-ribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus. Br J Rheum 32:663-665
28. Abdel-Nasser AM, Abd El-Azim S, Taal E et al (1998) Depression and depressive symptoms in rheumatoid arthritis patients: An analysis of their occurrence and determinants. Br J Rheumatol 37:391-397
29. Arnett FC, Reveille JD, Moustopoulos HM et al (1996) Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum 39:1833-1839
30. Sfikakis PP, Mitsikostas DD, Manoussakis MN et al (1998) Headache in systemic lupus erythematosus. Br J Rheumatol 37:300-303
31. Appenzeller S, Costallat LT (2004) Clinical implications of migraine in systemic lupus erythematosus: Relation to cumulative organ damage. Cephalalgia 24:1013-1015
32. Weiner S, Otte A, Schumacher M et al (2000) Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 59:377-385
33. Harrison MJ (2002) Cognitive dysfunction in neuropsychiatric systemic lupus erythematosus. Curr Opin Rheumatol 14:510-514
34. Sanna G, Bertolaccini ML, Cuadrado MJ et al (2003) Neuropsychiatric manifestations in systemic lupus erythematosus: Prevalence and association with antiphospholipid antibodies. J Rheumatol 30:985-992
35. Teh L-S, Isenberg DA (1994) Anti-ribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal. Arthritis Rheum 37:307-315
36. Teh L-S, Bedwell AE, Isenberg DA et al (1992) Antibodies to protein P in systemic lupus erythematosus. Ann Rheum Dis 51:489-494
37. Reichlin M, Broyles TF, Hubscher O et al (1999) Prevalence of autoantibodies to ribosomal P proteins in juvenile onset systemic lupus erythematosus compared with the adult disease. Arthritis Rheum 42:69-75
38. Ghirardello A, Doria A, Zampieri S et al (2000) Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: Their specificity for SLE and association with IgG anticardiolipin antibodies. Ann Rheum 59:975-981
39. Karassa FB, Afeltra A, Ambrozic A et al (2006) Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: An international meta-analysis. Arthritis Rheum 54:312-324